<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>SCINAI IMMUNOTHERAPEUTICS RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Thu, 09 Apr 2026 00:27:51 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/scinai%5Fimmunotherapeutics%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>SCINAI IMMUNOTHERAPEUTICS RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>Scinai CEO Amir Reichman to Co-Lead Manufacturers Association Biopharma Manufacturing Roundtable at HealthIL</title><pubDate>Wed, 07 Jan 2026 13:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/scinai-ceo-amir-reichman-to-co-lead-manufacturers-association-biopharma-manufacturing-roundtable-at-healthil-15398533</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">JERUSALEM, <span class="legendSpanClass"><span class="xn-chron">Jan. 7, 2026 /PRNewswire/ -- <b>Scinai Immunotherapeutics Ltd.</b> (Nasdaq: SCNI); ("Scinai",  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/scinai-ceo-amir-reichman-to-co-lead-manufacturers-association-biopharma-manufacturing-roundtable-at-healthil-15398533</guid></item><item><title>Scinai Immunotherapeutics: So schnitt der Konzern im vergangenen Quartal ab</title><pubDate>Thu, 04 Dec 2025 06:35:06 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/scinai-immunotherapeutics-so-schnitt-der-konzern-im-vergangenen-quartal-ab-15334068</link><description><![CDATA[<p><a href="https://www.finanzen.net/aktien/scinai_immunotherapeutics-aktie">Scinai Immunotherapeutics</a> hat am 02.12.2025 Zahlen zum jüngsten Quartal vorgelegt, das am 30.09.2025 endete.Scinai Immunotherapeutics vermeldete für das jüngste Quartal einen Verlust je Aktie von 4,74  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/scinai-immunotherapeutics-so-schnitt-der-konzern-im-vergangenen-quartal-ab-15334068</guid></item><item><title>Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances</title><pubDate>Tue, 02 Dec 2025 14:50:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/scinai-reports-nine-month-2025-results-as-cdmo-growth-continues-and-nanoabs-pipeline-advances-15328248</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">JERUSALEM, <span class="legendSpanClass"><span class="xn-chron">Dec. 2, 2025 /PRNewswire/ -- <b>Scinai Immunotherapeutics Ltd.</b> (Nasdaq: SCNI) ("Scinai",  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/scinai-reports-nine-month-2025-results-as-cdmo-growth-continues-and-nanoabs-pipeline-advances-15328248</guid></item></channel></rss>
